Alkermes plc is a biopharmaceutical company that develops pharmaceutical products for unmet medical needs. It has a portfolio of proprietary products for alcohol dependence, opioid dependence, schizophrenia, and bipolar I disorder. Marketed products include ARISTADA, ARISTADA INITIO, VIVITROL, and LYBALVI. The company has collaboration agreements with Janssen Pharmaceutica companies. Alkermes also offers technology platforms to third parties. Founded in 1987, the company is headquartered in Dublin, Ireland.
Indicator | Value |
---|---|
PER | 11.9 |
EV/EBITDA | 10.1 |
Price/Free Cash Flow' | 10.8 |
ROIC | 18.3% |
Net Debt/EBITDA | 1.3 |